Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

An official website of the United States government

Genetic and Genomic Testing Evidence-Based Programs Listing

Several hereditary conditions can raise the risk of getting cancer. Two of the most common are hereditary breast and ovarian cancer HBOC syndrome and Lynch syndrome. People with HBOC syndrome have a higher risk for breast, ovarian, advanced prostate, and pancreatic cancers and people with Lynch syndrome have a higher risk for colorectal, uterine, and ovarian cancers. Understanding family health history helps provide a more complete picture of individual risk factors for disease. Genetic counseling is important for understanding if an individual and their family are likely to benefit from genetic testing, and for understanding testing results. In the age of precision medicine, genetic counseling is also important for educating patients about tumor molecular profiling (also called biomarker testing). This EBCCP program area includes programs focused on assessment of hereditary cancer risk, tumor profiling, and patient and family education.

Use the search bar or filters to find programs on genetic counseling and testing. For more information, visit the Genetic and Genomic Testing Recommendations page.



Open/Close Additional Information Program Title & Description
Program Area Sub Categories Population Focus Suitable Settings Level of Change Program Focus Community Type Age Age Sex Race/Ethnicity Origination Program Materials Language Purpose Program URL Sub Topics
Genetic and Genomic Testing Adults Health Care Facilities Individual; Interpersonal Cognitive or Psychosocial Determinants; Healthcare Satisfaction and/or Utilization; Shared Decision Making Suburban or Urban 18-39 Years (Young Adults); 40-65 Years (Adults); 65+ Years (Older Adults) 18-39 Years ; 40-65 Years ; 65+ Years Female Black or African American (not Hispanic or Latino); Hispanic or Latino; White (not Hispanic or Latino) United States English Designed to enhance knowledge in the decision making process for genetic testing for breast cancer susceptibility. https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=277363
Genetic and Genomic Testing; Survivorship Cancer Survivors Email, Website, Phone, Postal Mail, or Mass Media; Health Care Facilities; Homes Individual Cognitive or Psychosocial Determinants; Healthcare Satisfaction and/or Utilization Suburban or Urban 18-39 Years (Young Adults); 40-65 Years (Adults); 65+ Years (Older Adults) 18-39 Years ; 40-65 Years ; 65+ Years Female; Male Black or African American (not Hispanic or Latino); Hispanic or Latino; White (not Hispanic or Latino) United States English The program is designed to increase patients’ understanding of tumor genetic testing. https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=35471150
Genetic and Genomic Testing Cancer Survivors Email, Website, Phone, Postal Mail, or Mass Media Interpersonal Capability or Motivation for Behavior Change; Cognitive or Psychosocial Determinants; Healthcare Satisfaction and/or Utilization; Shared Decision Making Rural; Suburban or Urban 18-39 Years (Young Adults); 40-65 Years (Adults); 65+ Years (Older Adults) 18-39 Years ; 40-65 Years ; 65+ Years Female Alaska Native; American Indian; Asian; Black or African American (not Hispanic or Latino); Hispanic or Latino; Native Hawaiian or Pacific Islander; White (not Hispanic or Latino) United States English; Spanish The program is designed to increase uptake of CGRA (i.e., genetic counseling and/or testing) among high-risk breast cancer or ovarian cancer survivors. https://ebccp.cancercontrol.cancer.gov/programDetails.do?programId=36085955